prime health tirzepatide is a next-generation dual agonist that targets both GLP-1 and GIP receptors to help regulate appetite, support metabolic balance, and drive meaningful weight loss. To match your unique physiology and treatment Weight Loss Program - Prime
Description
GLP-1 receptor agonists work to lower blood sugar and improve how your body uses insulin
The success of $NOVO's Ozempic/Wegovy probably hasn't escaped anyone at this point, but the growth in absolute dollar terms is *insane*
Personalized programs, ongoing check-ins, and a supportive patient experience.
Which One Is Better for Weight Loss?
Hormone targeting, metabolism, dosing, and individual response explained.
Women using both treatments lost 17% of their body weight on average, compared to 14% in those not using hormone therapyand nearly half achieved dramatic 20%+ weight loss.
